Lakshya-1 test flown successfully
Balasore (Odisha): India`s indigenously
developed micro-light pilot-less target aircraft `Lakshya-1`
was successfully test flown from the Integrated Test Range at
Chandipur near here today as part of a routine trial.
‘Lakshya-1’, fitted with an advanced digitally controlled
engine was once again test flown at about 1.10 PM
successfully. It was flight tested from a mobile launcher from
launch pad-II of ITR, defence sources said.
"The flight test was a routine trial by the users," they
Usually, the flight duration of the micro light aircraft
is 30 to 35 minutes. But test is conducted for enhancement of
the flight duration and to check other parameters, the sources
‘Lakshya’, a sub-sonic, re-usable aerial target system is
remote controlled from the ground and designed to impart
training to both air borne and air defence pilots.
The PTA has been developed by India’s aeronautic
development establishment (ADE), Bangalore to perform discreet
aerial reconnaissance of battle field and target acquisition.
‘Lakshya’ has been inducted into the Indian Air Force
(IAF) since 2000.
While a successful trial of Lakshya was conducted on
January 30, Lakshya-11 had been test flown on January 25 and
27 successfully from the same ground.
More from India
More from World
More from Sports
More from Entertaiment
- Will implement 'One Rank, One Pension' without fail: PM Modi
- Defence Minister Manohar Parrikar stands in a queue at Pune wedding!
- Delhi: Shakuntala Gamlin writes to LG against AAP minister
- Jharkhand's Health Minister slaps political rival in public
- One Rank, One Pension: What is complicating its implementation? Part-2
- Check CHSE orrisharesults.nic.in, chseodisha.nic.in for Class 12 (Plus Two) Result 2015
- Will ask SC if India can pursue Captain Saurabh Kalia case against Pakistan in ICJ: Sushma Swaraj
- IMD predicts thundershowers in Delhi, Punjab and UP between June 1-3
- Salman, Aamir, Shah Rukh in a film together?
- Even 100 Rahul Gandhis cannot match PM Narendra Modi's mega wave: Shiv Sena